Provided by Tiger Fintech (Singapore) Pte. Ltd.

LUCID DIAGNOSTICS INC.

1.30
+0.01000.78%
Post-market: 1.340.0388+2.98%19:59 EDT
Volume:859.61K
Turnover:1.11M
Market Cap:140.65M
PE:-1.03
High:1.34
Open:1.31
Low:1.26
Close:1.29
Loading ...

Lucid Diagnostics Raises $15.3 Million in Stock Offering

TIPRANKS
·
06 Mar

Lucid Diagnostics Announces Closing of $15.3 Million Registered Direct Offering

THOMSON REUTERS
·
06 Mar

Lucid Diagnostics Prices $15.3 Million Direct Offering

MT Newswires Live
·
04 Mar

Lucid Diagnostics to sell 13.94M shares at $1.10 in registered direct offering

TIPRANKS
·
04 Mar

Lucid Diagnostics Announces $15.3 Million Registered Direct Offering

PR Newswire
·
04 Mar

Lucid Diagnostics Inc: Announces $15.3 Million Registered Direct Offering

THOMSON REUTERS
·
04 Mar

Lucid Diagnostics Inc - Terminates Atm Prospectus Supplement Dated Dec 6, 2022

THOMSON REUTERS
·
04 Mar

Renowned Investigators Awarded $8 Million Nih Grant to Study Lucid Diagnostics' Esoguard® in at-Risk Patients Without Symptomatic Gerd

THOMSON REUTERS
·
27 Feb

Renowned Investigators Awarded $8 Million NIH Grant to Study Lucid Diagnostics' EsoGuard® in At-Risk Patients without Symptomatic GERD

PR Newswire
·
27 Feb

Lucid Diagnostics Regains Compliance With Nasdaq Minimum Bid Price Requirement

THOMSON REUTERS
·
25 Feb

Lucid Diagnostics Regains Compliance with Nasdaq Minimum Bid Price Requirement

PR Newswire
·
25 Feb

Lucid Diagnostics Inc - Regains Compliance With Nasdaq $1 Minimum Bid Price on Feb 24

THOMSON REUTERS
·
25 Feb

BRIEF-PAVmed Regains Compliance With Nasdaq Stockholders' Equity Requirement

Reuters
·
18 Feb

PAVmed Regains Compliance With Nasdaq Stockholders' Equity Requirement

THOMSON REUTERS
·
18 Feb

PAVmed Regains Compliance with Nasdaq Stockholders' Equity Requirement

PR Newswire
·
18 Feb

Lucid Diagnostics to Participate in the 12th Annual BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

PR Newswire
·
06 Feb

Lucid Diagnostics Announces Record Quarterly EsoGuard® Test Volume

PR Newswire
·
13 Jan

Lucid Inks New Partnership With VITALExam: Stock to Gain?

Zacks
·
26 Dec 2024

Lucid Diagnostics Secures 180-Day Extension to Regain Compliance With Nasdaq Listing Rules

MT Newswires Live
·
24 Dec 2024

Lucid Diagnostics granted 180-day extension by Nasdaq to regain compliance

TIPRANKS
·
23 Dec 2024